Waivers and Alterations of Research Informed Consent During the COVID-19 Pandemic.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33315470.
- Also identified by DOI 10.7326/M20-6993 and PMC identifier 7745118.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The COVID-19 pandemic poses distinct challenges for the conduct of minimal-risk clinical research, including the very definition of minimal risk, the heterogeneity of risk among potential study participants, privacy concerns, and practical issues in recruitment and written informed consent.
Medical subject headings
- Biomedical Research
- COVID-19
- Informed Consent
- Pandemics